학술논문
Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease.
Document Type
Article
Author
Source
Subject
*SARS-CoV-2
*COVID-19
*TREATMENT effectiveness
*THERMOPHORESIS
*
*
*
Language
ISSN
1932-6203
Abstract
Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 Mpro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this study we examined the binding of the Apixaban, Betrixaban and Rivaroxaban to the SARS-CoV-2 Mpro with the use of the MicroScale Thermophoresis technique. Our results indicate that the experimentally measured binding affinity is weak and the therapeutic effect due to the SARS-CoV-2 Mpro inhibition is rather negligible. [ABSTRACT FROM AUTHOR]